新闻BenzingaEloxx Pharmaceuticals Finalizes Design For Its EXPRESS Phase 2 Global Trial In Nonsense-Mutation Autosomal Dominant Polycystic Kidney Disease To Enrolol 60 Adults With Genetically Confirmed PKD1 Or PKD2 Nonsense Mutations Eloxx Pharmaceuticals Finalizes Design For Its EXPRESS Phase 2 Global Trial In Nonsense-Mutation Autosomal Dominant Polycystic Kidney Disease To Enrolol 60 Adults With Genetically Confirmed PKD1 Or PKD2 Nonsense Mutations Benzinga 2026.10.20 13:36 (GMT+0) 在Benzinga上打开 其他新闻 美国电力公司将季度股息从每股0.95美元上调至0.97美元 DA Davidson维持对Zions Bancorp的“买入”评级，将目标价上调至80美元 如果你在5年前投资了1000美元购买TechnipFMC股票，如今你将拥有这么多钱 分析师关注奈飞财报前广告收入激增30亿美元 DA Davidson维持对Private Bancorp的买入评级，将目标价上调至107美元 诺斯罗普·格鲁曼 2026年第三季度财报电话会议记录
